Clinical Research Studies for Idiopathic Pulmonary Fibrosis (IPF)
- Patients with a current diagnosis of IPF
- Men and Women over 40 years of age
- Approximately 4-5 years of commitment with regular office visits
- Patient compensation provided for time and participation
If you are eligible and enroll, you will receive all study-related care at no cost. You will also receive monitoring of your IPF by a research doctor.
For additional details or if you have questions, please call (425) 225-2780 or email firstname.lastname@example.org.
What is IPF?
Idiopathic Pulmonary Fibrosis is when lung tissue becomes scarred and damaged without a known cause (idiopathic). The lungs become thick and stiff, making it difficult for your lungs to work properly, and as pulmonary fibrosis becomes worse it will become harder to breathe.
Conditions that contribute to IPF:
- Environmental Factors such as asbestos exposure, silica dust, bird and animal droppings.
- Radiation Treatments for cancer can cause some lung damage, depending on amount of exposure.
- Medications that can damage your lungs may include: Chemotherapy, heart rhythm drugs, and some antibiotics.
- Medical Conditions like: Pneumonia, Tuberculosis, Lupus, Scleroderma, Rheumatoid Arthritis, and Sarcoidosis.
The list of causes and conditions that can lead to pulmonary fibrosis is long. However, in most cases, the cause cannot be found, which is referred to as idiopathic or “unknown cause.
There are several theories about what might trigger idiopathic pulmonary fibrosis, including tobacco smoke and viruses. Because idiopathic pulmonary fibrosis has also been seen to run in families, genes or heredity may also be a factor.
- Shortness of breath (dyspnea)
- A dry cough
- Unexplained weight loss
- Aching muscles and joints
IPF Clinical Trials
You may quality for a clinical research study for those suffering from Idiopathic Pulmonary Fibrosis.
For additional details or if you have questions, please call (425) 225-2760 or email email@example.com.